REG - Mothercare PLC - License agreement with Ebebek Mağazacılık A.Ş.

MothercareAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250623:nRSW9317Na&default-theme=true

RNS Number : 9317N  Mothercare PLC  23 June 2025

Mothercare plc

License agreement with Ebebek Mağazacılık A.Ş.

Mothercare plc ("Mothercare" or "the Company"), the leading specialist global
brand for parents and young children, is pleased to announce a new license
agreement for Turkey, with Ebebek Mağazacılık A.Ş.  ("Ebebek"). Ebebek is
the leading retailer in this sector in Turkey meeting all  the needs of
mother and baby from the prenatal period up to the age of four.

In Turkey, Ebebek has around 280 stores and an on line business producing
revenues of around £400m, together with 3 stores recently opened in the UK.
The new license agreement will give Ebebek the exclusive right to use the
Mothercare brand in Turkey on products either designed and sourced by Ebebek
or Mothercare for a period of 10 years. It also gives Mothercare the right to
re-brand certain Ebebek own brand products with the Mothercare brand and sell
outside of the territories where Ebebek trades.

Clive Whiley, Chairman of Mothercare, commented:

"Today's agreement following on from our joint venture with Reliance
Industries announced last year is further evidence of the strength, inherent
value and global appeal of the Mothercare brand and the value it can add, with
businesses that are already market leaders in their territory. We look forward
to working together with Ebebek to establish Mothercare as an important part
of their business.

We are in discussions with several other parties to further restore critical
mass alongside delivering our other core objectives. The underlying business
continues to prove its resilience, and the strength of the brand is evident
from the interest it generates and the ongoing discussions with other
potential strategic partners."

New License Agreement

Mothercare and Ebebek have entered in to a 10 year agreement, giving Ebebek
the exclusive right, solely within Turkey, to use the Mothercare brand on
products they design or source, subject to our prior approval and in
accordance with our guidelines and standards. Ebebek may also purchase
Mothercare branded products from us solely for sale within Turkey. On the sale
of any Mothercare branded product Ebebek will pay a percentage of the sale as
a royalty. The agreement also allows Mothercare to purchase products Ebebek
has sourced for itself, either under its own brands or Mothercare, for sale by
our franchise partners outside of the territories where Ebebek trades and to
re-brand these products with the Mothercare brand if relevant.

The shares of Ebebek, which went public in 2023, are traded on Borsa
Istanbul's Stars Market under the code EBEBK.

This new agreement will not only provide additional revenue to our Company but
will also potentially enable us to obtain synergies and the resultant
benefits, from combining the purchasing power of our two businesses.

Investor and analyst enquiries to:

Mothercare plc
                 Email: investorrelations@mothercare.com
(mailto:investorrelations@mothercare.com)

Clive Whiley, Chairman

Andrew Cook, Chief Financial
Officer
 

 

Deutsche
Numis
          Tel: 020 7260 1000

(NOMAD & Joint Corporate Broker)

Luke Bordewich

Henry Slater

Cavendish Capital Markets Limited
      Tel: 020 7220 0500

(Joint Corporate
Broker)

Matt Goode

Media enquiries to:

MHP
 
Email: mothercare@mhpgroup.com

Rachel
Farrington                                                          Tel: 07739
312199

Tim Rowntree

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGRFTMMTMTMTTIA